NIH cuts target $1.6 billion RECOVER initiative to study and improve treatment of long COVID, putting further research gains ...

Australian scientists developed a novel antiviral that targets the SARS-CoV-2 PLpro enzyme, showing strong preclinical ...

It was 2024—a point at which most people in America considered the pandemic long since over. But it wasn’t for me. Some days, ...

A former triathlete whose terminal cancer was initially mistaken for long Covid has been given months to live. Olivia Knowles ...

With few specialized clinics, dwindling federal support, and ongoing insurance battles, long COVID patients in San Diego face ...

Major market sell-offs typically occur about once every five to 10 years, according to a study, but they come at various ...

This week, we’re writing about a power workout, the neurocognitive effects of long covid and nine popular supplements. Plus, ...

Researchers have shown a new drug compound can prevent long COVID symptoms in mice – a landmark finding that could lead to a future treatment for the debilitating condition.

OpEd: Both predominately impact women so it’s no coincidence that each lacks educational resources, community/family support networks and research funding.

A novel decentralized clinical trial found that Paxlovid was ineffective in alleviating long COVID symptoms but underscored the importance of a patient-centered approach.

However, she said taking part in a clinical research trial at Glenfield Hospital, in Leicester, had allowed her to get her ...

The US National Institutes of Health (NIH) appears to be reversing course on its decision to abruptly cancel a spate of grants for long COVID research earlier this week. On Friday, the NIH Office ...